{"title":"你应该治疗糖尿病前期吗?这很复杂。","authors":"Daniel Holligan, Roxanne Radi, Corey Lyon","doi":"10.12788/jfp.0652","DOIUrl":null,"url":null,"abstract":"<p><p>While treatment with metformin or lifestyle modification reduces risk for T2D in patients with prediabetes, neither intervention ultimately offers a mortality benefit.</p>","PeriodicalId":54836,"journal":{"name":"Journal of Family Practice","volume":"72 7","pages":"E23-E25"},"PeriodicalIF":1.3000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515438/pdf/0720e23.pdf","citationCount":"0","resultStr":"{\"title\":\"Should you treat prediabetes? It's complicated.\",\"authors\":\"Daniel Holligan, Roxanne Radi, Corey Lyon\",\"doi\":\"10.12788/jfp.0652\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>While treatment with metformin or lifestyle modification reduces risk for T2D in patients with prediabetes, neither intervention ultimately offers a mortality benefit.</p>\",\"PeriodicalId\":54836,\"journal\":{\"name\":\"Journal of Family Practice\",\"volume\":\"72 7\",\"pages\":\"E23-E25\"},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515438/pdf/0720e23.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Family Practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.12788/jfp.0652\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Family Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.12788/jfp.0652","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
While treatment with metformin or lifestyle modification reduces risk for T2D in patients with prediabetes, neither intervention ultimately offers a mortality benefit.
期刊介绍:
JFP is a peer-reviewed medical journal specifically intended to meet the needs of the specialty of family medicine. JFP is delivered to more than 95,000 family physicians as well as general practitioners and osteopaths in primary care.